Envista (NYSE:NVST) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Envista (NYSE:NVST) released its quarterly earnings results on Wednesday. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05, FiscalAI reports. The business had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.04 million. Envista had a net margin of 2.41% and a return on equity of 7.09%. The company’s quarterly revenue was up 14.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.24 earnings per share. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Here are the key takeaways from Envista’s conference call:

• Envista reported a strong Q1 with core sales up 9.5% (≈4% normalized excluding extra billing days and Spark deferral), adjusted EBITDA +25% and adjusted EPS +50%, and management reaffirmed full‑year 2026 guidance.
• Leadership expanded shareholder returns, authorizing an incremental $300 million buyback (1.6M shares purchased in Q1) while maintaining a conservative balance sheet with net debt <1x adjusted EBITDA.
• Continued investment and execution — double‑digit increases in sales & marketing and R&D, plus Envista Business System gains — drove a 100 bps gross margin uplift and 120 bps adjusted EBITDA margin improvement.
• Regional and policy risks pose near‑term headwinds, notably VBP-related channel destocking in China causing double‑digit implant declines there, plus geopolitical uncertainty in the Middle East and a looming Q4 billing‑day timing headwind.
• Cash and cost dynamics are mixed — Q1 free cash flow was a seasonal –$16M as CapEx rose for new facilities and tariffs added about $11M of costs, but management still expects roughly 100% free cash flow conversion for 2026.

Envista Trading Down 0.5%

Shares of NVST traded down $0.13 on Friday, hitting $24.16. 3,006,877 shares of the stock traded hands, compared to its average volume of 2,853,331. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $3.94 billion, a P/E ratio of 59.10, a P/E/G ratio of 1.85 and a beta of 0.92. The stock’s 50 day moving average is $26.53 and its two-hundred day moving average is $24.06. Envista has a 1 year low of $16.41 and a 1 year high of $30.42.

Insiders Place Their Bets

In other Envista news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at $971,460. This trade represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.99% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Envista

A number of large investors have recently bought and sold shares of the stock. Parallel Advisors LLC raised its stake in Envista by 13.1% during the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after purchasing an additional 367 shares during the period. Bank of Montreal Can raised its stake in Envista by 1.4% during the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after purchasing an additional 372 shares during the period. Sepio Capital LP raised its stake in Envista by 1.2% during the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after purchasing an additional 374 shares during the period. Deutsche Bank AG raised its stake in Envista by 2.9% during the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after purchasing an additional 484 shares during the period. Finally, UMB Bank n.a. raised its stake in Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after purchasing an additional 636 shares during the period.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on NVST. JPMorgan Chase & Co. increased their price target on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday. Evercore reiterated an “outperform” rating and issued a $33.00 price target on shares of Envista in a research report on Thursday. Barclays upped their price objective on shares of Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research note on Wednesday, February 11th. Wall Street Zen raised shares of Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Finally, Leerink Partners set a $35.00 price objective on shares of Envista and gave the company an “outperform” rating in a research note on Friday, February 6th. Six investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $28.83.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.